{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T15:58:36Z","timestamp":1793203116724,"version":"4.5.0"},"update-to":[{"DOI":"10.1016\/j.jconrel.2019.10.004","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2019,12,28]],"date-time":"2019-12-28T00:00:00Z","timestamp":1577491200000}}],"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT094085MA"],"award-info":[{"award-number":["WT094085MA"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014538","name":"Lembaga Pengelola Dana Pendidikan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014538","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jconrel.2019.10.004","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T12:32:24Z","timestamp":1571833944000},"page":"34-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":208,"special_numbering":"C","title":["RETRACTED: Solid lipid nanoparticle-based dissolving microneedles: A promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis"],"prefix":"10.1016","volume":"316","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0063-077X","authenticated-orcid":false,"given":"Andi Dian","family":"Permana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismaiel A.","family":"Tekko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mael\u00edosa T.C.","family":"McCrudden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qonita Kurnia","family":"Anjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delly","family":"Ramadon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1254-3745","authenticated-orcid":false,"given":"Helen O.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0766-4147","authenticated-orcid":false,"given":"Ryan F.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2019.10.004_bib0005","series-title":"Global Programme to Eliminate Lymphatic Filariasis: Progress Report","author":"WHO","year":"2018"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0010","series-title":"Alternative Mass Drug Administration Regimens to Eliminate Lymphatic Filariasis","author":"WHO","year":"2017"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1948-7134.2010.00076.x","article-title":"Laboratory and field testing of bednet traps for mosquito (Diptera: Culicidae) sampling in West Java, Indonesia","volume":"35","author":"Stoops","year":"2010","journal-title":"J. Vector Ecol."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0020","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-3024.2001.00400.x","article-title":"Wolbachia bacteria in filarial immunity and disease","volume":"23","author":"Taylor","year":"2003","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0025","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/QCO.0b013e328315cde7","article-title":"Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis","volume":"21","author":"Hoerauf","year":"2008","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.vaccine.2018.12.015","article-title":"Immunogenicity and protective efficacy of Recombinase A from Wolbachia endosymbiont of filarial nematode Brugia malayi (wBmRecA)","volume":"37","author":"Gangwar","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0035","series-title":"Lymphatic filariasis, Lymphat. Filariasis","author":"WHO","year":"2019"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0169-409X(01)00151-X","article-title":"Intestinal lymphatic drug transport: an update","volume":"50","author":"Porter","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0045","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0168-3659(96)01588-X","article-title":"Potential for lymphatic targeting of peptides","volume":"46","author":"Muranishi","year":"1997","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0050","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1007\/s00044-011-9763-5","article-title":"Modeling, docking, simulation, and inhibitory activity of the benzimidazole analogue against b -tubulin protein from Brugia malayi for treating lymphatic filariasis","volume":"21","author":"Sharma","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0055","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/jps.21954","article-title":"Biowaiver monographs for immediate release solid oral dosage forms: doxycycline hyclate","volume":"99","author":"Jantratid","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0060","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrd4608","article-title":"From sewer to saviour-targeting the lymphatic system to promote drug exposure and activity","volume":"14","author":"Trevaskis","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0065","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1517\/17425247.2013.771630","article-title":"Nanopharmaceuticals to target antifilarials: a comprehensive review","volume":"10","author":"Ali","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0070","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1021\/acs.molpharmaceut.6b00206","article-title":"Subcutaneously administered ultrafine PLGA nanoparticles containing doxycycline hydrochloride target lymphatic filarial parasites","volume":"13","author":"Singh","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ijpharm.2014.05.027","article-title":"Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting","volume":"471","author":"Tiantian","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425247.2014.915310","article-title":"Solid lipid nanoparticles of diethylcarbamazine citrate for enhanced delivery to the lymphatics: in vitro and in vivo evaluation","volume":"11","author":"Siram","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0085","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2009.08.005","article-title":"PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats","volume":"140","author":"Kaminskas","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijbiomac.2018.11.230","article-title":"Enhanced transdermal lymphatic delivery of doxorubicin via hyaluronic acid based transfersomes\/microneedle complex for tumor metastasis therapy","volume":"125","author":"Yang","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0095","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/08982109709035487","article-title":"Lymphatic uptake and biodistribution of liposomes after subcutaneous injection I. Influence of the anatomical site of injection","volume":"7","author":"Oussoren","year":"1997","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0100","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.2042-7158.2012.01599.x","article-title":"A nanoparticle depot formulation of 4-(N)-stearoyl gemcitabine shows a strong antitumor activity","volume":"65","author":"Zhu","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0105","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ejps.2011.12.016","article-title":"Modified Rose Bengal assay for surface hydrophobicity evaluation of cationic solid lipid nanoparticles (cSLN)","volume":"45","author":"Doktorovova","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2012.09.021","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"64","author":"Mehnert","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0115","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.addr.2003.12.002","article-title":"Solid lipid nanoparticles for parenteral drug delivery","volume":"56","author":"Wissing","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0120","first-page":"2733","article-title":"Advanced drug delivery to the lymphatic system: lipid-based nanoformulations","volume":"8","author":"Khan","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0125","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejps.2006.01.001","article-title":"Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases","volume":"28","author":"Lu","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0130","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2014.04.052","article-title":"Current advances in the fabrication of microneedles for transdermal delivery","volume":"185","author":"Indermun","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0897-1897(04)00079-5","article-title":"Intradermal injections: traditional bevel up versus bevel down","volume":"17","author":"Tarnow","year":"2004","journal-title":"Appl. Nurs. Res."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0140","series-title":"Microneedle-mediated Transdermal and Intradermal Drug Delivery","author":"Donnelly","year":"2012"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0145","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijpharm.2017.02.011","article-title":"Successful application of large microneedle patches by human volunteers","volume":"521","author":"Ripolin","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11095-010-0169-8","article-title":"Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique","volume":"28","author":"Donnelly","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0155","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejps.2018.05.009","article-title":"Dissolving polymeric microneedle arrays for enhanced site-specific acyclovir delivery","volume":"121","author":"Pamornpathomkul","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0160","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jconrel.2018.12.026","article-title":"Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response","volume":"294","author":"Niu","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0165","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jconrel.2004.01.005","article-title":"Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles","volume":"95","author":"Venkateswarlu","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0170","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.carbpol.2010.12.042","article-title":"Effect of chitosan coating in overcoming the phagocytosis of insulin loaded solid lipid nanoparticles by mononuclear phagocyte system","volume":"84","author":"Sarmento","year":"2011","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0175","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejps.2012.05.010","article-title":"Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?","volume":"47","author":"Das","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0180","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.biomaterials.2010.09.037","article-title":"The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen","volume":"32","author":"Jain","year":"2011","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0190","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","article-title":"DDSolver: An add-in program for modeling and comparison of drug dissolution profiles","volume":"12","author":"Zhang","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0111547","article-title":"Hydrogel-forming microneedles prepared from \u201csuper swelling\u201d polymers combined with lyophilised wafers for transdermal drug delivery","volume":"9","author":"Donnelly","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0200","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2018.02.031","article-title":"Transdermal delivery of vitamin K using dissolving microneedles for the prevention of vitamin K deficiency bleeding","volume":"541","author":"Hutton","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0205","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jconrel.2017.07.032","article-title":"Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis","volume":"265","author":"Gonz\u00e1lez-V\u00e1zquez","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0210","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2014.05.042","article-title":"A proposed model membrane and test method for microneedle insertion studies","volume":"472","author":"Larra\u00f1eta","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0215","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jconrel.2018.11.002","article-title":"Design, formulation and evaluation of novel dissolving microarray patches containing a long-acting rilpivirine nanosuspension","volume":"292","author":"Mc Crudden","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0220","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/pharmaceutics11070346","article-title":"Enhanced intradermal delivery of nanosuspensions of antifilariasis drugs using dissolving microneedles: a proof of concept study","volume":"11","author":"Permana","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0225","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0230","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jpba.2019.03.047","article-title":"New HPLC\u2013MS method for rapid and simultaneous quantification of doxycycline, diethylcarbamazine and albendazole metabolites in rat plasma and organs after concomitant oral administration","volume":"170","author":"Permana","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0235","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/jps.21604","article-title":"Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system","volume":"98","author":"Dhuria","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0240","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/10717544.2013.838713","article-title":"Insights into direct nose to brain delivery: current status and future perspective","volume":"21","author":"Mittal","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0245","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1208\/s12249-015-0391-0","article-title":"Enhancement of bioavailability and pharmacodynamic effects of thymoquinone via nanostructured lipid carrier (NLC) formulation","volume":"17","author":"Elmowafy","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0250","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jddst.2017.02.001","article-title":"Enhancing bioavailability and controlling the release of glibenclamide from optimized solid lipid nanoparticles","volume":"38","author":"Elbahwy","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0255","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ejps.2013.03.013","article-title":"Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride","volume":"49","author":"Vaghasiya","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0260","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2008.10.002","article-title":"Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles","volume":"133","author":"Li","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0265","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.lwt.2014.04.058","article-title":"Development and evaluation of lipid nanocarriers for quercetin delivery: a comparative study of solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), and lipid nanoemulsions (LNE)","volume":"59","author":"Aditya","year":"2014","journal-title":"LWT Food Sci. Technol."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0270","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1021\/mp4006968","article-title":"Solid lipid nanoparticle formulations of docetaxel prepared with high melting point triglycerides: in vitro and in vivo evaluation","volume":"11","author":"Naguib","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0275","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.2147\/IJN.S91556","article-title":"Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers","volume":"10","author":"El-Helw","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0280","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2019.02.002","article-title":"Simvastatin-loaded solid lipid nanoparticles for enhanced anti- hyperlipidemic activity in hyperlipidemia animal model a Riphah","volume":"560","author":"Zaki","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0285","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0939-6411(97)00150-1","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery - Drug release and release mechanism","volume":"45","author":"Zur M\u00fchlen","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0290","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejpb.2013.12.015","article-title":"Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism","volume":"87","author":"Ravi","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0295","first-page":"1","article-title":"In vitro release kinetics of antituberculosis drugs from nanoparticles assessed using a modified dissolution apparatus","volume":"2013","author":"Gao","year":"2013","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0300","first-page":"217","article-title":"Kinetic modelling on drug release from controlled drug delivery systems","volume":"67","author":"Dash","year":"2010","journal-title":"Acta Pol. Pharm. Drug Res."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0305","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijpharm.2019.05.066","article-title":"Rapidly dissolving bilayer microneedle arrays \u2013 a minimally invasive transdermal drug delivery system for vitamin B12","volume":"566","author":"Ram\u00f6ller","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0310","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1080\/03602559.2014.979506","article-title":"Poly(vinylpyrrolidone) \u2013 a versatile polymer for biomedical and beyond medical applications","volume":"54","author":"Teodorescu","year":"2015","journal-title":"Polym. - Plast. Technol. Eng."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0315","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.biotechadv.2018.11.008","article-title":"Biomaterials of PVA and PVP in medical and pharmaceutical applications: perspectives and challenges","volume":"37","author":"Teodorescu","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0320","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s11095-014-1301-y","article-title":"Hydrogel-forming microneedle arrays can be effectively inserted in skin by self-application : a pilot study centred on pharmacist intervention and a patient information leaflet","volume":"31","author":"Donnelly","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0325","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jconrel.2010.08.008","article-title":"Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution","volume":"147","author":"Donnelly","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0330","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2017.04.022","article-title":"In vivo studies investigating biodistribution of nanoparticle-encapsulated rhodamine B delivered via dissolving microneedles","volume":"265","author":"Kennedy","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0335","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijpharm.2016.12.010","article-title":"Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): an improved dermatokinetic profile for inflammatory disorder(s)","volume":"517","author":"Garg","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0340","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijpharm.2015.12.061","article-title":"Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-\u03baB and FOXO1","volume":"499","author":"Garg","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0345","first-page":"122","article-title":"The lymphatics of the skin filled by a dermal backflow: an obsevation in a scarred cadaver leg","volume":"40","author":"Suami","year":"2007","journal-title":"Lymphology."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0350","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0731-7085(02)00382-5","article-title":"HPLC assay for albendazole and metabolites in human plasma for clinical pharmacokinetic studies","volume":"30","author":"Kitzman","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0355","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11095-010-0109-7","article-title":"Enhanced bioavailability of L-carnitine after painless intradermal delivery vs. oral administration in rats","volume":"28","author":"Zhang","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0360","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2014.04.051","article-title":"Nano-chemotherapeutics: Maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers","volume":"193","author":"Ryan","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0365","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/jsre.2000.6075","article-title":"Comparison of intradermal and subcutaneous injections in lymphatic mapping 3404","volume":"96","author":"Kersey","year":"2001","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.jconrel.2019.10.004_bib0370","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2014.06.053","article-title":"Quantitative analysis of drug delivery to the brain via nasal route","volume":"189","author":"Kozlovskaya","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.10.004_bib0375","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2017.05.001","article-title":"A strategy for bypassing the blood-brain barrier: facial intradermal brain-targeted delivery via the trigeminal nerve","volume":"258","author":"Yu","year":"2017","journal-title":"J. Control. Release"}],"updated-by":[{"DOI":"10.1016\/j.jconrel.2019.10.004","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2019,12,28]],"date-time":"2019-12-28T00:00:00Z","timestamp":1577491200000}},{"DOI":"10.1016\/j.jconrel.2026.114842","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000}},{"DOI":"10.1016\/j.jconrel.2026.114842","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000}}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919305735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919305735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T21:40:43Z","timestamp":1785966043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365919305735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":75,"alternative-id":["S0168365919305735"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.10.004","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Solid lipid nanoparticle-based dissolving microneedles: A promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}